Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 4 29-4, 2003, Pages

  Vargaftig, B Boris ^a   Singer, Monique ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Asthma; Epidermal growth factor receptor; Hyperreactivity; Inflammation; Mucus; Remodeling

Indexed keywords

1 ETHYL 6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 2 QUINOLONE; 1 HYDROXY 3 (3 HYDROXY 7 PHENYL 1 HEPTENYL) 1 CYCLOHEXANEACETIC ACID; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ALPHA ACTIN; ARACHIDONATE 5 LIPOXYGENASE; BROXURIDINE; CHEMOKINE; COLLAGEN; DEXAMETHASONE; EOSINOPHIL PEROXIDASE; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LEUKOTRIENE C4; MESSENGER RNA; METHACHOLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; MUCIN; MYELOPEROXIDASE; OVALBUMIN; PEPTIDOLEUKOTRIENE; TOMELUKAST; UNCLASSIFIED DRUG; VERLUKAST; ZILEUTON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG LAVAGE; MALE; MOUSE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0141568044     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00377.2002     Document Type: Article

References (50)

1. Aharony D. Pharmacology of leukotriene receptor antagonists. Am J Respir Crit Care Med 157: S214-S219, 1998.
2. Amishima M, Munakata M, Nasuhara Y, Sato A, Takahashi T, Homma Y, and Kawakami Y. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Respir Crit Care Med 157: 1907-1912, 1998.
3. Basbaum C, Lemjabbar H, Longphre M, Li D, Gensch E, and McNamara N. Control of mucin transcription by diverse injury-induced signalling pathways. Am J Respir Crit Care Med 160: S44-S48, 1999.
4. Bonner JC. The epidermal growth factor receptor at the crossroads of airway remodeling. Am J Physiol Lung Cell Mol Physiol 283: L528-L530, 2002.
5. Busse D, Doughty RS, Ramsey TT, Russell WE, Price JO, Flanagan WM, Shawver LK, and Arteaga CL. Reversible G1 arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27 Kip1 independent of MAPK activity. J Biol Chem 275: 6987-6995, 2000.
6. Chu SJ, Tang LO, Watney E, Chi E, and Henderson W. In situ amplification of 5-lipoxygenase-activating protein in allergic airway inflammation and inhibition by leukotriene blockade. J Immunol 163: 4640-4648, 2000.
7. Colle JH, Falanga P, Singer M, Hevin B, and Milon G. Quantification of messenger RNA by competitive RT-PCR: a simplified read out assay. J Immunol Methods 210: 175-184, 1997.
8. Daniels SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, Faux JA, Ryan GF, le Souef PN, Lathrop GM, Musk AW, and Cookson WO. A genome-wide search for quantitative trait loci underlying asthma. Nature 383: 247-250, 1996.
9. Daser A, Daheshia M, and De Sanctis GT. Genetics of allergen-induced asthma. J Allergy Clin Immunol 108: 167-174, 2001.
10. Ediger TL, Danforth BL, and Toews ML. Lysophosphatidic acid upregulates the epidermal growth factor receptor in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 282: L91-L98, 2002.
11. Ewart SL, Kuperman D, Schadt E, Tankersley C, Grupe A, Shubitowski DM, Peltz G, and Wills-Karp M. Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am J Respir Cell Mol Biol 23: 537-545, 2000.
12. Fleisch JH, Rinkema LE, Haisch KD, Swanson-Bean D, Goodson T, Ho PPK, and Marshall WS. LY171883,1->2-hydroxy-3-propyl-4-(1H-tetrazol-5-yl) butoxy
13. Funk CD. Lipid-mediator-deficient mice in models of inflammation. In: Molecular and Cellular Basis of Inflammation, edited by Serhan CN and Ward PA. Totowa, NJ: Humana, 1999, p. 109-125.
14. Ganter P and Jolles G. Histochimie normale et pathologique, T2. Paris: Gauthier-Villars, 1970, p. 1424-1425.
15. Hallé S, Lefort J, Joseph D, Gounon P, Huerre M, and Vargaftig BB. Mucous-cell metaplasia and inflammatory-cell recruitment are dissociated in allergic mice after antibody- and drug-dependent cell depletion in a murine model of asthma. Am J Respir Cell Mol Biol 20: 1-12, 1999.
16. Hakonarson H, Bjornsdottir US, Halapi E, Palsson S, Adalsteinsdottir E, Gislason D, Finnbogason G, Gislason T, Kristjansson K, Arnason T, Birkisson I, Frigge ML, Kong A, Gulcher JR, and Stefansson K. A major susceptibility gene for asthma maps to chromosome 14q24. Am J Hum Genet 71: 483-491, 2002.
17. Hammelmann E, Takeda K, Haczku A, Cieslewicz G, Schultz L, Hamid Q, Xing Z, Gauldie J, and Gelfand EW. Interleukin-5 but not immunoglobulin E reconstitutes airway inflammation and airway hyperresponsiveness in IL-4 deficient mice. Am J Respir Cell Mol Biol 23: 327-334, 2000.
18. Henderson WR, Lewis DB, Albert RK, Zhang Y, Lamm WJE, Chiang GKS, Jones F, Eriksen P, Tien Y, Jonas M, and Chi E. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 184: 1483-1494, 1996.
19. Henderson WR Jr, Tang L-O, Chu SJ, Tsao SM, Chiang GKS, Jones F, Jonas M, Pae C, Wang H, and Chi E. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Crit Care 165: 108-116, 2002.
20. Hullot P, Poudrel JM, Muller A, Escale R, Rossi JC, Girard JP, and Bonne JC. Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*,3S*)-1-Hydroxy-3-{(3R* S*,E)-3-hydroxy-7-phenyl-1-hepten-1yl}-1-cyclohexane acetate. Arzneim Forsch 47: 51-58, 1997.
21. Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Frenette R, Gauthier JY, Leger S, and Masson P. Pharmacology of L-600,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol 67: 17-28, 1989.
22. Kalmes A and Clowes AW. EGFR transactivation in the regulation of SMC function. Ann NY Acad Sci 947: 42-54, 2001.
23. Kim KC, Nassiri J, and Brody JS. Mechanisms of airway goblet cell mucin release: studies with cultured tracheal surface epithelial cells. Am J Respir Cell Mol Biol 1: 137-143, 1989.
24. Klein A, Talvani A, Silva PMR, Martins MA, Wells TNC, Proudfoot A, Luckacs NW, and Teixeira MM. Stem cell factor-induced leukotriene B4 production cooperates with eotaxin to mediate the recruitment of eosinophils during allergic pleuresy in mice. J Immunol 167: 524-531, 2001.
25. Konstant MW, Walenga RW, Hillard KA, and Hillard JB. Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis 148: 896-901, 1993.
26. Lam BK. Biochemical and molecular characterization of LTC4 synthase. ACI International 9: 3-5, 1997.
27. Lefort J, Singer M, Leduc D, Renesto P, Nahori MA, Huerre M, Creminon C, Chignard M, and Vargaftig BB. Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-α formation and neutrophil sequestration into the murine lungs. J Immunol 161: 474-480, 1998.
28. Marom Z, Shelhamer JH, and Bach M. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 126: 449-454, 1982.
29. McCole DF, Keely SJ, Coffey RJ, and Barrett KE. Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J Biol Chem 277: 42603-42712, 2002.
30. McGill KA and Busse WW. Zileuton. Lancet 348: 519-524, 1996.
31. Nasuhara Y, Munakata M, Sato A, Amishima M, Homma Y, and Kawakami Y. Mechanisms of epidermal growth factor-induced contraction of guinea-pig airways. Eur J Pharmacol 296: 161-168, 1996.
32. Newberry RD, Stenson WF, and Lorenz RG. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 5: 900-906, 1999.
33. Peters-Golden M. Molecular mechanisms of leukotriene synthesis: the changing paradigm. Clin Exp Allergy 28: 1059-1065, 1998.
34. Peters-Golden M, Bailie M, Marshall T, Wilke C, Phan SH, Toews GB, and Moore BB. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med 165: 229-235, 2002.
35. Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, Holgate ST, and Davies DE. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 14: 1362-1374, 2000.
36. Richter A, Puddicombe SM, Lordan JL, Bucchieri F, Wilson SJ, Djukanovic R, Dent G, Holgate ST, and Davies DE. The contribution of (IL)-4 and IL-13 to the epithelial-mesenchymal tropic unit in asthma. Am J Respir Cell Mol Biol 25: 385-391, 2001.
37. 4 on mucociliary function and airway mechanics in allergic sheep. J Appl Physiol 59: 1416-1422, 1983.
38. Schmidt DJ, Watson NW, Dent G, Rühlmann E, Branscheid D, Magnussen H, and Rabe KF. The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C4-induced contractions in passively sensitized human airways. Br J Pharmacol 131: 1607-1618, 2000.
39. Singer M, Lefort J, and Vargaftig BB, Granulocyte depletion and dexamethasone differentially modulate airways hyperreactivity, inflammation mucus accumulation and secretion induced by rmIL-13 or antigen. Am J Respir Cell Mol Biol 26: 74-84, 2002.
40. Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, Ueki IF, Grattan KM, and Nadel JA. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 96: 3081-3086, 1999.
41. Takeyama K, Dabbagh K, Shim JJ, Dao-Pick T, Ueki IF, and Nadel JA. Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol 164: 1546-1552, 2000.
42. Tamaoki J, Kondo M, Sakai N, Nakata J, Takemura H, Nagai A, Takizawa T, and Konno K. Leukotriene antagcnist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. Am J Crit Care 155: 1235-1240, 1997.
43. Toews ML, Ustinova EE, and Schultz HD. Lysophosphatidic acid enhances contractility of isolated airway smooth muscle. J Appl Physiol 83: 1216-1222, 1997.
44. Trifilieff A, El-Hashim A, and Bertrand C. Time coure of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 279: L1120-L1128, 2000.
45. Tsai W, Morielli AD, and Peralta EG. The m1 muscarinic acethylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J 15: 1037-1044, 1997.
46. Vargaftig BB and Singer M. Leukotrienes, IL-13, and chemokines cooperate for BHR and mucipare metaplasia in allergic mouse lungs. Am J Physiol Lung Cell Mol Physiol 284: L260-L269, 2003.
47. Vargaftig BB and Singer M, Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by rmIL-13. Am J Respir Cell Mol Biol 28: 410-419, 2003.
48. Wardlaw AJ, Hay H, Cromwell BO, Collins JV, and Kay AB. Leukotrienes LTC4, LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 84: 19-26, 1989.
49. Yamanaka Y, Hayashi K, Komurasaki T, Morimoto S, Ogihara T, and Sobue K. EGF family ligand-dependent phenotypic modulation of smooth muscle cells through EGF receptor. Biochem Biophys Res Commun 281: 373-377, 2001.
50. Ye RD. Regulation of nuclear factor-κB activation by G protein-coupled receptors. J Leukoc Biol 70: 839-848, 2001.